Sale!

IVD Gene Isovaleric Acidemia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The IVD Gene Isovaleric Acidemia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the IVD gene, which are responsible for Isovaleric Acidemia (IVA). Isovaleric Acidemia is a rare genetic disorder characterized by the body’s inability to properly break down a particular amino acid called leucine, leading to the accumulation of isovaleric acid in the blood, which can be toxic and cause serious health issues. Early detection through this genetic test allows for timely intervention and management of the condition, improving the quality of life for affected individuals.

The test is priced at 3200 AED and involves analyzing the patient’s DNA to look for specific mutations in the IVD gene. The process is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results. This test is particularly important for families with a history of Isovaleric Acidemia, as it can help in making informed decisions regarding family planning and in implementing dietary and medical interventions that can significantly reduce the impact of the disorder.

Description

IVD Gene Isovaleric acidemia Genetic Test

Test Name: IVD Gene Isovaleric acidemia Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 3200.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for IVD Gene Isovaleric acidemia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Isovaleric acidemia.

Test Details:

IVD gene isoform analysis is a genetic test that uses next-generation sequencing (NGS) technology to analyze the IVD gene for mutations associated with isovaleric acidemia. Isovaleric acidemia is a rare genetic disorder characterized by the inability to break down the amino acid leucine properly, leading to the accumulation of toxic levels of isovaleric acid in the body.

NGS technology allows for the simultaneous analysis of multiple genes, including the IVD gene, in a high-throughput manner. This enables the identification of various mutations and variants within the gene that may be responsible for the development of isovaleric acidemia.

The IVD gene encodes the enzyme isovaleryl-CoA dehydrogenase, which is responsible for breaking down isovaleryl-CoA, a byproduct of leucine metabolism. Mutations in the IVD gene can result in a deficiency or complete absence of this enzyme, leading to the accumulation of isovaleryl-CoA and subsequent isovaleric acidemia.

By analyzing the IVD gene using NGS technology, healthcare professionals can identify specific mutations or variants that may be responsible for isovaleric acidemia in an individual. This information can be used for accurate diagnosis, genetic counseling, and potentially targeted treatment approaches for affected individuals.

Test Name	IVD Gene Isovaleric acidemia Genetic Test
Components
Price	3200.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for IVD Gene Isovaleric acidemia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Isovaleric acidemia
Test Details	IVD gene isoform analysis is a genetic test that uses next-generation sequencing (NGS) technology to analyze the IVD gene for mutations associated with isovaleric acidemia. Isovaleric acidemia is a rare genetic disorder characterized by the inability to break down the amino acid leucine properly, leading to the accumulation of toxic levels of isovaleric acid in the body. NGS technology allows for the simultaneous analysis of multiple genes, including the IVD gene, in a high-throughput manner. This enables the identification of various mutations and variants within the gene that may be responsible for the development of isovaleric acidemia. The IVD gene encodes the enzyme isovaleryl-CoA dehydrogenase, which is responsible for breaking down isovaleryl-CoA, a byproduct of leucine metabolism. Mutations in the IVD gene can result in a deficiency or complete absence of this enzyme, leading to the accumulation of isovaleryl-CoA and subsequent isovaleric acidemia. By analyzing the IVD gene using NGS technology, healthcare professionals can identify specific mutations or variants that may be responsible for isovaleric acidemia in an individual. This information can be used for accurate diagnosis, genetic counseling, and potentially targeted treatment approaches for affected individuals.